Phil Maples Email and Phone Number
Phil Maples work email
- Valid
- Valid
Phil Maples personal email
Phil Maples phone numbers
• More than 36 years of experience in Biotechnology / Healthcare• Cell, Tissue and Gene Therapies Development focused on Cancers, Immunotherapies, Inherited Diseases and Healingo Antigen-specific T Cells, Dendritic Cells and Stem Cells o Autologous and Allogeneic Cancer Cell Vaccineso Oncolytic Viruseso Viral Based Gene Delivery – AAV, Adenovirus, Retrovirus, Vacciniao Nonviral Based Gene Delivery – Electroporation / Liposomal• Liposomal, other Nanoparticle Drug Delivery Formulations Development• Protein-based Therapeutics Development• Combination Device Products• CPC and cGMP Facility Design / Build Out / Operation / Compliance• GMP Process Design / Implementation / Analytical Support• Stability Studies / Packaging / Labeling / Placebo Controls• Regulatory Planning and Submissions / FDA / RAC / International• IND (CMC) Preparation / Reporting • Preclinical Study Designs / Execution• Clinical Trials Designs / Coordination• Quality Assurance Structure / SOP Development / Training / Audits • Supply Chain / Inventory Control / Logistics
Laurus Bio
View- Website:
- richcoreindia.com
- Employees:
- 420
-
Laurus BioPortugal
-
Executive DirectorLaurus Bio 2014 - PresentBiotechnology Consulting for Biologics Development and cGMP Production Facilities
-
Co-Owner And ManagerH M Bio, Llc Sep 2016 - PresentImmunotherapeutics
-
Vp, Process DevelopmentAbeona Therapeutics May 2017 - Jun 2022Cleveland, Oh, Us -
Vp, Process DevelopmentAbeona Therapeutics May 2017 - Jun 2022Cleveland, Oh, Us
-
Executive V.P. And Chief Technical Officer, Formerly Vp Technical OperationsGradalis, Inc. May 2005 - Jan 2014Designed and built current development labs with two sets of GMP suites: Phase I/II trials manufacturing of Cancer Vaccines (TAG, then FANG) and plasmid DNAs for bi-shRNA (RNAi) trials (STMN I and PDX-1)Developed FANG vaccine from concept to Phase II in less than two years (3 Phase II studies)6 INDs, 6 Phase I and 5 Phase II studies submitted, approved and initiated since 2007Built IP portfolio for both vaccines and RNAi / delivery franchises Developed and was responsible for GMP Manufacturing, Product Development, Inventory Control, Purchasing and Quality Assurance (QC)Successful in obtaining non-dilutive funds to support initiatives (ETF, CPRIT, STTR, SBIR) Co-created founding IP for G-Con, LLC – manufacturer of GMP Pod systems (www.gconbio.com)
-
Vp Clinical Development And Manufacturing And Corporate OfficerCellexsys / Chromos Aug 2001 - May 2005Developed Ag-specific T Cell Therapy for chronic HBV (REM Expansion TechnologyRaised key corporate funding in JapanTransitioned Company through Chromos mergerDeveloped additional Cancer / Infectious Disease Applications of technology Developed clinical sites, protocols, etc. in Asia, North America and Europe with supporting strategic manufacturing initiatives
-
Scientific Director, Head Of The Molecular/Cell Processing CenterUs Oncology (Formerly Prn) Mar 1998 - Aug 2001Designed and oversaw construction of cell processing facility as a Baxter programEstablished multistate GTP-compliant PBSC transplant processing network for USONDeveloped / performed Phase I/II Manufacturing for Clients (ex. GVAX NSCLC vaccine)Performed first successful viral-based IV gene therapy trial (ONYX-015 oncolytic Ad)
-
Associate Scientific Director (Operating Division Facility Quality Manager)Baxter Healthcare Aug 1986 - Feb 1998Deerfield, Illinois, UsCreated successful ex vivo gene therapy for CGD; used ex vivo processing system for X-linked SCID and other ex vivo cell and gene therapiesTwo CRADAs with NIH; develop new Cell Processing Center and CGD gene therapyGenerated an ISO 9000 Quality System for Operating Division; obtained CE Mark (TUV)Substantially improved Division’s cash flow by working with Sales and Marketing to develop new market segments and through CE Mark generated salesDeveloped neutrophil expansion system for CD34+ cells (patented)Manufacturing and 510k submissions for ex vivo closed cell processing componentsDesigned Cell Processing Centers for Baxter clients using Isolex
Phil Maples Skills
Phil Maples Education Details
-
University Of ChicagoErythropoietin In Dr. Eugene Goldwasser'S Laboratory -
Ou Health Sciences CenterBiochemistry And Molecular Biology
-
Wood'S Hole Marine Biology LaboratorySummer Embryology Course
-
Ou Health Sciences CenterAttended College Of Pharmacy
-
The University Of TulsaMicrobiology
Frequently Asked Questions about Phil Maples
What company does Phil Maples work for?
Phil Maples works for Laurus Bio
What is Phil Maples's role at the current company?
Phil Maples's current role is Executive Director, Laurus Bio LLC.
What is Phil Maples's email address?
Phil Maples's email address is pm****@****ics.com
What is Phil Maples's direct phone number?
Phil Maples's direct phone number is +197295*****
What schools did Phil Maples attend?
Phil Maples attended University Of Chicago, Ou Health Sciences Center, Wood's Hole Marine Biology Laboratory, Ou Health Sciences Center, The University Of Tulsa.
What skills is Phil Maples known for?
Phil Maples has skills like Biotechnology, Biochemistry, Fda, Gmp, Clinical Development, Biopharmaceuticals, Life Sciences, Cell Culture, Medical Devices, Molecular Biology, R&d, Cell.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial